Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
Advisory Committee on Immunization Practices (ACIP) Advisory Committee on Immunization Practices (ACIP)
Advisory Committee on Immunization Practices (ACIP)

The ACIP is a group of medical and public health experts that develops recommendations on the use of vaccines in the civilian population of the United States. The ACIP holds three meetings each year at the Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia to make vaccine recommendations. Meetings are open to the public and available online via webcast. More information on ACIP is available at: https://www.cdc.gov/vaccines/acip/index.html.

1 - 20 of 1381 Results
View:
Sort By:
Refine Results
All Collections
Small Close Icon
Refine Results:
All Collections
Small Close Icon
Narrow Results:
Publish Year
More
Genre
More
Document Type
More
Subject
More
Name as Subject
More
Place as Subject
More
  • Advisory Committee on Immunization Practices (ACIP) summary report : February 24-25, 2010, Atlanta, Georgia
    Filetype[PDF - 2.44 MB]
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2010 February 24-25 : Atlanta, GA)
    Published Date:
    2010
    Series:
    ACIP meeting Minutes
    Description:
    min-feb10.pdf
    File Type:
    Filetype[PDF - 2.44 MB]
    File Type:
    Filetype[PDF - 2.44 MB]
  • ACIP COVID-19 Vaccines Work Group, December 19, 2020
    Filetype[PDF - 501.54 KB]
    Personal Author:
    Bell, Beth P.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 December 19-20, 2020 : Atlanta, GA)
    Published Date:
    December 19, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    01-COVID-Bell-508.pdf
    File Type:
    Filetype[PDF - 501.54 KB]
    File Type:
    Filetype[PDF - 501.54 KB]
  • Overview of Moderna’s COVID-19 Vaccine (mRNA-1273)
    Filetype[PDF - 704.27 KB]
    Personal Author:
    Miller, Jacqueline M.
    Corporate Authors:
    Moderna (firm)
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 December 19-20, 2020 : Atlanta, GA)
    Published Date:
    December 19, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    02-COVID-Miller-508.pdf
    File Type:
    Filetype[PDF - 704.27 KB]
    File Type:
    Filetype[PDF - 704.27 KB]
  • Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine
    Filetype[PDF - 570.75 KB]
    Personal Author:
    Gargano, Julia W.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 December 19-20, 2020 : Atlanta, GA)
    Published Date:
    December 19, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    03-COVID-Gargano-508.pdf
    File Type:
    Filetype[PDF - 570.75 KB]
    File Type:
    Filetype[PDF - 570.75 KB]
  • EtR Framework : Moderna COVID-19 vaccine
    Filetype[PDF - 4.20 MB]
    Personal Author:
    Oliver, Sara E.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 December 19-20, 2020 : Atlanta, GA)
    Published Date:
    December 19, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    slides-12-19/04-COVID-Oliver-508.pdf
    File Type:
    Filetype[PDF - 4.20 MB]
    File Type:
    Filetype[PDF - 4.20 MB]
  • Anaphylaxis following m-RNA COVID-19 vaccine receipt
    Filetype[PDF - 599.17 KB]
    Personal Author:
    Clark, Thomas A.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 December 19-20, 2020 : Atlanta, GA)
    Published Date:
    December 19, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    05-COVID-CLARK-508.pdf
    File Type:
    Filetype[PDF - 599.17 KB]
    File Type:
    Filetype[PDF - 599.17 KB]
  • Use of mRNA COVID-19 vaccines : interim clinical considerations
    Filetype[PDF - 1.43 MB]
    Personal Author:
    Mbaeyi, Sarah A.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 December 19-20, 2020 : Atlanta, GA)
    Published Date:
    December 19, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    06-COVID-Mbaeyi-508.pdf
    File Type:
    Filetype[PDF - 1.43 MB]
    File Type:
    Filetype[PDF - 1.43 MB]
  • ACIP COVID-19 Vaccines Work Group, December 20, 2020
    Filetype[PDF - 449.76 KB]
    Personal Author:
    Bell, Beth P.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 December 19-20, 2020 : Atlanta, GA)
    Published Date:
    December 20, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    01-COVID-Bell-508.pdf
    File Type:
    Filetype[PDF - 449.76 KB]
    File Type:
    Filetype[PDF - 449.76 KB]
  • Phased allocation of COVID-19 vaccines
    Filetype[PDF - 968.80 KB]
    Personal Author:
    Dooling, Kathleen
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 December 19-20, 2020 : Atlanta, GA)
    Published Date:
    December 20, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    02-COVID-Dooling-508.pdf
    File Type:
    Filetype[PDF - 968.80 KB]
    File Type:
    Filetype[PDF - 968.80 KB]
  • Considerations for populations Included in Phase 1b and 1c
    Filetype[PDF - 1.05 MB]
    Personal Author:
    Oliver, Sara E.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 December 19-20, 2020 : Atlanta, GA)
    Published Date:
    December 20, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    03-COVID-Oliver-508.pdf
    File Type:
    Filetype[PDF - 1.05 MB]
    File Type:
    Filetype[PDF - 1.05 MB]
  • BNT162b2 vaccine candidate against COVID-19
    Filetype[PDF - 3.27 MB]
    Personal Author:
    Gruber, William
    Corporate Authors:
    Pfizer Ltd ; BioNTech SE ;
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 December 11-12, 2020 : Atlanta, GA)
    Published Date:
    December 11, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    COVID-02-Gruber-508.pdf
    File Type:
    Filetype[PDF - 3.27 MB]
    File Type:
    Filetype[PDF - 3.27 MB]
  • Grading of recommendations, assessment, development, and evaluation (GRADE) : Pfizer BioNTech COVID-19 vaccine
    Filetype[PDF - 599.51 KB]
    Personal Author:
    Gargano, Julia W.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 December 11-12, 2020 : Atlanta, GA)
    Published Date:
    December 11, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    COVID-03-Gargano.pdf
    File Type:
    Filetype[PDF - 599.51 KB]
    File Type:
    Filetype[PDF - 599.51 KB]
  • Work Group interpretation and next steps